- Mega deal: La Jolla startup Synthorx sells for $2.5 billion to Sanofi The San Diego Union-Tribune
- Sanofi, Maker of World’s Top-Selling Insulin, to Exit Diabetes Research The Wall Street Journal
- Sanofi to Buy Synthorx for $2.5 Billion Yahoo Finance
- Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value Fortune
- Sanofi to acquire Synthorx for $2.5 billion MarketWatch
- View full coverage on Google News
